We want to put special focus on solidarity." The original motto, the Latin 'Citius, Altius, Fortius', was adopted by the founder of the modern Games Pierre De Coubertin in the 19th century. The Latin ...

After nabbing an FDA approval last summer for its T-cell lymphoma treatment Lymphir, Citius Oncology is eyeing strategic alternatives. The company, a subsidiary of Citius Pharmaceuticals ...

Citius, Altius, Fortius. It’s a term that belongs to the Olympics – the International Olympic Committee has wisely had its motto trademarked – but it could just as easily describe hockey.

D. Boral Capital upgraded Citius Pharmaceuticals (CTXR) to Buy from Hold with a $9 price target. Citius owns 90% of Citius Oncology (CTOR), which is close to commercializing Lymphir, an ...

CRANFORD, N.J., Jan. 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to ...

https://www.tipranks.com/news/the-fly/ventyx-biosciences-highlights-its-2025-pipeline-strategy Citius Pharma ( (CTXR) ) has released its Q4 earnings. Here is a ...

The show’s title is taken from the Olympic motto ‘Citius, Altius, Fortius - Communiter’ meaning ‘Faster, Higher, Stronger - ...

CRANFORD, N.J., Jan. 6, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or "the Company") (Nasdaq: CTOR), a majority-owned subsidiary of Citius ...

Citius Pharma ( (CTXR)) has released its Q4 earnings. Here is a breakdown of the information Citius Pharma presented to its investors. Citius Pharmaceuticals, Inc. is a biopharmaceutical company ...